MARX Biotech Co (ROCO:7731) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
8 GF Score
Price NT$4.69
! 5 Warning Signs
View Full Analysis

What is MARX Biotech Co 5-Year Yield-on-Cost %?

MARX Biotech Co ROCO:7731 +0.43% 8 5-Year Yield-on-Cost % is 0.00 as of Aug. 18, 2026. GuruFocus rates ROCO:7731 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 277 Healthcare Providers & Services companies, MARX Biotech Co ranks worse than 361010.47% on this metric.

MARX Biotech Co's yield on cost for the quarter that ended in Dec. 2025 was 0.00.


The historical rank and industry rank for MARX Biotech Co's 5-Year Yield-on-Cost % or its related term are showing as below:



ROCO:7731's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.87
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

MARX Biotech Co  (ROCO:7731) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


MARX Biotech Co 5-Year Yield-on-Cost % Related Terms


MARX Biotech Co 5-Year Yield-on-Cost % Competitor Comparison

For the Pharmaceutical Retailers subindustry, MARX Biotech Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MARX Biotech Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where MARX Biotech Co's 5-Year Yield-on-Cost % falls into.


ROCO:7731
8GF Score
MARX Biotech Co Ltd ROCO:7731
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MARX Biotech Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of MARX Biotech Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
MARX Biotech Co (ROCO:7731) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 18, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on MARX Biotech Co and its competitors. According to the industry distribution chart, MARX Biotech Co ranks #999999 out of 277 companies in the Healthcare Providers & Services industry.
Is MARX Biotech Co's 5-Year Yield-on-Cost % too high?
MARX Biotech Co's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, MARX Biotech Co ranks #999999 out of 277 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MARX Biotech Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's 5-Year Yield-on-Cost % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MARX Biotech Co ranks #999999 out of 277 companies for 5-Year Yield-on-Cost %. This places MARX Biotech Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.87, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on MARX Biotech Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MARX Biotech Co's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. MARX Biotech Co's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
8GF Score

Get the complete analysis for ROCO:7731

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.69
Price